Genexine, Inc. Extraordinary meeting on Nov 20 to add medical AI and data center businesses
GAI summary · Not investment advice
Genexine, Inc. will hold an extraordinary shareholders' meeting on November 20 to vote on amending its articles to add medical AI and data center businesses.
Key facts
- Meeting type
- Extraordinary shareholders' meeting
- Venue
- Main auditorium, 1st floor, Bio Innovation Park, Magok, Gangseo-gu, Seoul
- Voting record date
- Oct 21, 2026
- Agenda item 1
- Amendment of the articles of incorporation
- Board resolution date
- Oct 6, 2026
Commentary
AI commentary · Not investment advice
What happened
Genexine will hold an extraordinary shareholders' meeting on November 20. The only agenda item is amending the articles of incorporation, the company's basic rules. It adds business purposes such as running medical and bio data centers, cloud and AI data center solutions, server installation and hosting, and AI medical robotics. The company cited new plans for medical AI and data center businesses.
In the company's terms
Shareholders on record as of October 21 can vote. The meeting starts at 09:00 in the main auditorium on the first floor of Bio Innovation Park in Magok, Gangseo-gu, Seoul. The company said the board will confirm and re-file any changes to the agenda details.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist